A Case of toxic epidermal necrolysis induced by allopurinol
Hitit Medical Journal · 29.06.2026 · 8 (2) · 440-445
DOI: 10.52827/hititmedj.1779165 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hitit Medical Journal, online erschienen am 29.06.2026. Verfasst von Nazlı Yorulmaz und 3 weiteren Autor:innen. Die Arbeit nennt 13 Literaturangaben. Gefördert von: There are no financial funds for this article.
Abstract (Originalsprache)
Allopurinol reduces urate production by inhibiting xanthine oxidase. It is oxidatively hydroxylated to oxypurinol. It is the most commonly prescribed drug for the treatment of gout. Although it has a beneficial effect in the treatment of this common disease, it is also known to have numerous side effects. The most dangerous side effects associated with allopurinol use are Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN).These immune-mediated disease processes affect nearly every organ system. It is important to diagnose them as early as possible, as they can be fatal and require discontinuation of the drug at the first sign of SJS/TEN, such as a rash or other early symptoms. This case is important in terms of being careful against toxic drug reactions that may develop due to allopurinol use in elderly patients with gout.
Förderung
- There are no financial funds for this article
Zitieren
APA
Yorulmaz, N., Yıldırım, M. B., Bölük, K. N., & Karabulut, A. (2026). A Case of toxic epidermal necrolysis induced by allopurinol. Hitit Medical Journal, 8(2), 440-445. https://doi.org/10.52827/hititmedj.1779165
Vancouver
Yorulmaz N, Yıldırım MB, Bölük KN, Karabulut A. A Case of toxic epidermal necrolysis induced by allopurinol. Hitit Medical Journal. 2026;8(2):440-445. doi:10.52827/hititmedj.1779165
BibTeX
@article{Yorulmaz2026,
author = {Yorulmaz, Nazlı and Yıldırım, Mert Burak and Bölük, Kübra Nursel and Karabulut, Alpaslan},
title = {A Case of toxic epidermal necrolysis induced by allopurinol},
journal = {Hitit Medical Journal},
year = {2026},
volume = {8},
number = {2},
pages = {440--445},
doi = {10.52827/hititmedj.1779165}
}
EUVIMED